Adeno-associated virus vectors: activity and applications in the CNS

被引:124
|
作者
Peel, AL
Klein, RL
机构
[1] Buck Ctr Res Aging, Novato, CA 94948 USA
[2] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA
关键词
adeno-associated virus (AAV); disease-modeling; gene therapy; gene transfer; neurodegenerative disease; neurotrophic factor;
D O I
10.1016/S0165-0270(00)00183-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Transgenic strategies are useful for functional studies and they may also lead to novel therapies. Controlling transgene expression in defined cell populations over time is increasingly important for both functional and gene therapy experiments. The adeno-associated virus (AAV) vector may provide sufficient spatio-temporal control of gene expression for these purposes. This paper reviews in vivo somatic gene transfer methodology using AAV. Advantageous features of this system include neuronal gene expression that is: (1) efficient; (2) long-lived; and (3) non-toxic. Thus, AAV-mediated gene transfer is a good method for functional genomic research. From characterizing vector activity in the brain using different combinations of promoters and transgenes in the mid to late 1990s, researchers continue to discover novel uses of AAV for both basic and clinical neuroscience. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:95 / 104
页数:10
相关论文
共 50 条
  • [21] Immune responses to adeno-associated virus vectors
    Zaiss, AK
    Muruve, DA
    CURRENT GENE THERAPY, 2005, 5 (03) : 323 - 331
  • [22] Versatile applications of adeno-associated virus-based vectors in a transgenic facility
    Nickl, Petr
    Jenickova, Irena
    Kopkanova, Jana
    Yliperttula, Marjo
    Sedlacek, Radislav
    TRANSGENIC RESEARCH, 2022, 31 (SUPPL 1) : 12 - 12
  • [23] Protease-Activatable Adeno-Associated Virus Vectors for Cardiac Disease Applications
    Brun, Mitchell
    Guenther, Caitlin
    Kang, Brian
    Kwon, Sunkuk
    Sevick-Muraca, Eva
    Suh, Junghae
    MOLECULAR THERAPY, 2018, 26 (05) : 302 - 303
  • [24] Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications
    Schoen, Christian
    Biel, Martin
    Michalakis, Stylianos
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 95 : 343 - 352
  • [25] Intracellular transport of recombinant adeno-associated virus vectors
    M Nonnenmacher
    T Weber
    Gene Therapy, 2012, 19 : 649 - 658
  • [26] Recombinant adeno-associated virus vectors for gene therapy
    Conlon, TJ
    Flotte, TR
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) : 1093 - 1101
  • [27] Novel Cytotoxic Vectors Based on Adeno-Associated Virus
    Kohlschuetter, Johannes
    Michelfelder, Stefan
    Trepel, Martin
    TOXINS, 2010, 2 (12): : 2754 - 2768
  • [28] Engineering adeno-associated virus vectors for gene therapy
    Li, Chengwen
    Samulski, R. Jude
    NATURE REVIEWS GENETICS, 2020, 21 (04) : 255 - 272
  • [29] Innate immune responses to adeno-associated virus vectors
    Zaiss, AK
    White, LR
    Wong, NCW
    Bartlett, JS
    Muruve, DA
    MOLECULAR THERAPY, 2004, 9 : S283 - S284
  • [30] Adenovirus and adeno-associated virus as vectors for gene therapy
    Berns, KI
    Giraud, C
    DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 : 95 - 104